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Background: Chemokines and chemokine receptors cooperate to promote immune cell recruitment to the central
nervous system (CNS). In this study, we investigated the roles of CXCR2 and CXCL1 in leukocyte recruitment to the
CNS using a murine model of neuroinflammation.
Methods: Wild-type (WT), CXCL1−/−, and CXCR2−/− mice each received an intracerebroventricular (i.c.v.) injection of
lipopolysaccharide (LPS). Esterase staining and intravital microscopy were performed to examine neutrophil recruitment
to the brain. To assess endothelial activation in these mice, the expression of adhesion molecules was measured via
quantitative real-time polymerase chain reaction (PCR) and Western blotting. To identify the cellular source of functional
CXCR2, chimeric mice were generated by transferring bone marrow cells between the WT and CXCR2−/− mice.
Results: Expression levels of the chemokines CXCL1, CXCL2, and CXCL5 were significantly increased in the brain
following the i.c.v. injection of LPS. CXCR2 or CXCL1 deficiency blocked neutrophil infiltration and leukocyte
recruitment in the cerebral microvessels. In the CXCR2−/− and CXCL1−/− mice, the cerebral endothelial expression of
adhesion molecules such as P-selectin and VCAM-1 was dramatically reduced. Furthermore, the bone marrow transfer
experiments demonstrated that CXCR2 expression on CNS-residing cells is essential for cerebral endothelial activation
and leukocyte recruitment. Compared with microglia, cultured astrocytes secreted a much higher level of CXCL1 in
vitro. Astrocyte culture conditioned medium significantly increased the expression of VCAM-1 and ICAM-1 in cerebral
endothelial cells in a CXCR2-dependent manner. Additionally, CXCR2 messenger RNA (mRNA) expression in cerebral
endothelial cells but not in microglia or astrocytes was increased following tumor necrosis factor-α (TNF-α) stimulation.
The intravenous injection of the CXCR2 antagonist SB225002 significantly inhibited endothelial activation and leukocyte
recruitment to cerebral microvessels.
Conclusions: CXCL1 secreted by astrocytes and endothelial CXCR2 play essential roles in cerebral endothelial
activation and subsequent leukocyte recruitment during neuroinflammation.
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Immune cell recruitment is a key event in the develop-
ment of many types of central nervous system (CNS)
inflammatory diseases, such as bacterial meningitis [1],
stroke [2], and multiple sclerosis [3]. Following the
detection of pathogen-derived components or danger
signals, leukocyte recruitment to the brain via chemotaxis
[4, 5] occurs via a cascade-like process that involves the
expression of endothelial cell- and leukocyte-expressed
adhesion molecules such as selectins and integrins [6–8].
During the early stage of CNS inflammation, the interac-
tions between chemokines and their receptors also exert a
profound effect by attracting immune cells to migrate
across the blood–brain barrier (BBB) [9, 10].
CXCR2 is a G protein-coupled receptor that is acti-
vated by CXC chemokines, including murine CXCL1,
CXCL2, and CXCL5 [11, 12]. Interactions between
CXCR2 and its ligands play an essential role in mediat-
ing neutrophil migration to sites of inflammation.
Although extensive studies have focused on the role of
CXCR2 in inflammatory responses in different organs,
the involvement of individual chemokines in different
types of inflammatory responses remains contentious.
For example, CXCL1 is essential for the host pulmonary
defense to klebsiella infection [13] and mediates neutro-
phil recruitment during the progression of experimental
Lyme arthritis [14]. However, even in the presence of
high levels of CXCL1 expression, the interaction be-
tween CXCL2 and CXCR2 is still essential for neutrophil
migration in response to specific antigen challenge [15].
Additionally, CXCL2 plays a more important role than
CXCL1 in a viral antigen-induced delayed-type hyper-
sensitivity response [16]. Furthermore, CXCR2 is widely
expressed on neutrophils [17], lymphocytes [18], and
other types of non-hematopoietic cells, including epithe-
lial [19] and endothelial cells [20, 21]. Most studies have
focused on the functions of CXCR2 expressed on
hematopoietic cells, such as monocytes [22, 23] and
neutrophils [24–27]. However, recent studies have
revealed a critical role of CXCR2 expressed on non-
hematopoietic cells during inflammatory responses. In a
murine model of acute kidney infection, CXCR2 on
non-bone marrow-derived cells influenced the neutro-
phil response [19]. Additionally, CXCR2 expression on
resident cells is essential for the migration of mast cell
progenitors in the lung of antigen-challenged mice [28].
However, the roles of CXCR2 and its ligands in CNS in-
flammation remain to be addressed.
In this study, we performed intravital microscopy to
examine the role of CXCR2 in leukocyte recruitment
during neuroinflammation. We observed reduced neu-
trophil infiltration and attenuated leukocyte–endothelial
cell interactions in CXCR2−/− and CXCL1−/− mice fol-
lowing the intracerebroventricular (i.c.v.) injection oflipopolysaccharide (LPS). Moreover, CXCR2 or CXCL1
deficiency impaired endothelial activation by attenuating
the expression of adhesion molecules. Using chimeric
mice expressing CXCR2 on either hematopoietic cells or
radiation-resistant non-hematopoietic cells, we showed
that CXCR2 expression on radiation-resistant cells in
the CNS is essential for endothelial activation and subse-
quent leukocyte recruitment during neuroinflammatory
responses. Furthermore, a high level of CXCL1 was
detected in primary astrocyte culture and culture con-
ditioned medium significantly increased the expression
of VCAM-1 and ICAM-1 on cerebral endothelial cells.
Taken together, our findings revealed a previously
unrecognized role of CXCR2 expressed on cerebral
endothelial cells in the regulation of endothelial activa-




C57BL/6J mice (8 to 10 weeks old, 22 to 25 g) used as
wild-type controls were purchased from the Model Ani-
mal Research Center of Nanjing University. CXCR2−/−
mice (on the C57BL/6J background) were purchased
from the Jackson Laboratory (Bar Harbor, ME, USA). All
mice were maintained under environmentally controlled
conditions (ambient temperature, 22 ± 2 °C; humidity
40 %) in a pathogen-free facility with a 12-h light/dark
cycle and had access to water and food ad libitum.
All experimental procedures were performed in strict
accordance with the Institutional Animal Care and
Use Committee of Nanjing Medical University.
TALEN-mediated generation of CXCL1 knockout mice
To target the CXCL1 gene in the mouse genome, we
designed and synthesized highly active TALENs specific
to the CXCL1 gene. The TALEN target sequence for
CXCL1 was GATCCCAGCCACCCGC. TALEN messen-
ger RNAs (mRNAs) were diluted in RNase-free
phosphate-buffered saline (PBS) and then injected into the
cytoplasm of mouse pronuclear stage embryos to produce
mutant founders (F0). Heterozygous F1 offspring were
interbred to produce homozygous F2 animals. To func-
tionally validate the TALEN-induced mutations, we intra-
cerebroventricularly injected LPS into these mice and
measured the level of CXCL1 in the brain. No expression
of CXCL1 was detected in the CXCL1 mutant founder.
The CXCL1−/− mice were viable and fertile and did not
exhibit any gross abnormalities.
Intracerebroventricular injection of LPS
Intracerebroventricular injections into the mice were
performed as previously described [29]. Briefly, the mice
were anesthetized via intraperitoneal (i.p.) injection with
Wu et al. Journal of Neuroinflammation  (2015) 12:98 Page 3 of 15a mixture of 200 mg/kg ketamine and 10 mg/kg xyla-
zine. Then, 2 μg of LPS (dissolved in sterile saline at a
concentration of 1 μg/μl; Escherichia coli serotype
0111:B4 strain; Invivogen, Carlsbad, CA, USA) was
injected into the left ventricles using a microsyringe over
a 5-min period. Sham mice received isovolumetric sterile
saline injection. After LPS injection, the mice were
maintained under anesthesia at 36 ± 1 °C on a thermo-
static heating system (Harvard Apparatus, MA, USA) for
4 h before intravital microscopy was performed.
ELISA for chemokines
The mice were anesthetized after LPS injection and
subsequently perfused through the heart with 20 ml of
cold PBS over a period of 5 min to remove protein from
the blood circulation. Mouse brains were homogenized
in 1 ml of cold PBS and centrifuged at 12,000 rpm for
5 min at 4 °C. The CXCL1, CXCL2, and CXCL5 concen-
trations in the supernatant were measured using com-
mercial enzyme-linked immunosorbent assay (ELISA)
kits (R&D systems, Minneapolis, MN, USA) according
to the manufacturer’s instructions. The detection limit
was 15.6 pg/ml for all assays.
Flow cytometry
Flow cytometric analysis of single-cell suspensions pre-
pared from peripheral blood or spleens of wild-type or
CXCL1−/− mice was performed on a Beckman CytoFlex
(Beckman Coulter, Suzhou, China). Antibody clones
used for staining were specific for Gr-1 (RB6-8C5,
eBioscience, San Diego, USA), CD45 (30-F130,
eBioscience), and CXCR2 (TG11, Biolegend, San Diego,
CA, USA).
Immunohistochemistry
After anesthetization, the mice were transcardially per-
fused with ice-cold 4 % formalin. Then, the brains were
removed and fixed in 4 % formalin for 48 h. The
formalin-fixed tissues were embedded in paraffin and
then sliced into 4μm sections. Infiltrating neutrophils
were stained using a Naphthol AS-D Chloroacetate
Specific Esterase Kit (Sigma, St. Louis, MO, USA). We
selected more than four fields of view at a primary
magnification of ×200 in the cortex or hippocampus of
every brain section. Cells were counted under a Nikon
E100 microscope, and the data are presented as the
means ± SEM.
Intravital microscopy of the mouse brain
Intravital microscopy was performed as previously
described [29]. Briefly, after anesthetization, the right
parietal bone was subjected to craniotomy using a high-
speed drill. Subsequently, the dura were removed from
this site to expose the pial brain vessels. Rhodamine 6G(Sigma) was injected intravenously (0.5 mg/kg) into the
mouse to label the leukocytes. Then, a microscope
equipped with a fluorescent light source was used to
detect the leukocytes. The data were collected through a
sCMOS camera (ORCA-Flash 4.0, HAMAMATSU)
mounted on the microscope and stored for subsequent
analysis. Rolling leukocytes were defined as those cells
moving at a slower velocity than the erythrocytes; adher-
ent cells were defined as those that remained stationary
for at least 30 s.
RNA isolation and real-time quantitative PCR
After perfusion through the heart, the brains were
homogenized in 1 ml of TRIzol (Takara Bio, Inc., Shiga,
Japan) on ice, and RNA was extracted using TRIzol
reagent according to the protocol supplied by the manu-
facturer. A total of 1 μg of total RNA was reverse-
transcribed into cDNA. Then, SYBR® Green-based quan-
titative real-time polymerase chain reaction (PCR) was
performed with a Bio-rad CFX 96 Touch (Bio-Rad
Laboratories, Hercules, CA, USA) according to the man-
ufacturer’s instructions. β2-Macroglobulin (β2-MG) was
used as a housekeeping gene because its expression was
not influenced by the treatments. The amplification
conditions were as follows: 95 °C (2 min) followed by
32 cycles of 95 °C (20 s), 57.2 °C (30 s), and 72 °C (30 s).
Quantitative PCR assays were conducted in triplicate for
each sample and were performed using the 2−ΔΔCt
method. The amplified products were verified on a 1.5 %
agarose gel by electrophoresis. The data are expressed as
the n-fold differences relative to the standard.
Western blotting
After i.c.v. LPS injection, the mice were anesthetized and
perfused with ice-cold PBS to clear blood-borne proteins.
Next, the brain was homogenized in 1 ml of cold PBS on
ice, and the homogenate was centrifuged (12,000 rpm,
5 min). Cells were digested with radioimmunoprecipita-
tion assay (RIPA) lysis buffer (50 mmol/L Tris–HCl,
150 mmol/L NaCl, 1 % Nonidet-40, 0.5 % sodium deoxy-
cholate, 1 mmol/L EDTA, 1 mmol/L PMSF) for 30 min
on ice and centrifuged at 12,000 rpm for 15 min at 4 °C.
The brain homogenates or cell lysate were diluted in PBS
and loading buffer, boiled (100 °C, 10 min), loaded on a
10 % acrylamide–SDS gel, and transferred to a Protran
nitrocellulose membrane (Millipore, Billerica, MA, USA).
The membranes were blocked with 5 % dry milk in PBS
for 2 h at room temperature, incubated in primary anti-
bodies against P-selectin (ab178424, Abcam, Cambridge,
USA), E-selectin (ab18981, Abcam),VCAM-1 (ab134047,
Abcam), ICAM-1 (ab25375, Abcam), CXCR2 (ab14935,
Abcam), albumin (ab19194, Abcam), and β-actin (Cell
Signaling, Beverly, CA, USA) overnight at 4 °C, washed, in-
cubated in species-appropriate HRP-conjugated secondary
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washed three times. Then, the membranes were subjected
to immunodetection using enhanced chemiluminescence
reagents (PerkinElmer, Waltham, MA, USA).
Determination of albumin concentrations in brain
parenchyma
The mice were anesthetized and perfused with 20 ml of
cold PBS over a period of 10 min to remove proteins
from the blood circulation. Then, the concentration of
albumin, a serum protein that is normally excluded from
the brain by the intact blood–brain barrier, was mea-
sured in brain homogenates by Western blotting as
previously described [30].
Primary culture of purified microglia and astrocytes
After the neonatal cerebra were harvested, cerebral
cortices devoid of cerebella, white matter, and leptomen-
inges were trypsinized for 5 min and then filtered
through a 70-μm pore size filter. The cells from seven
cerebra were seeded on an uncoated 75-cm2 culture
flask and incubated in 40 ml of Dulbecco’s modified
essential media (DMEM)/F12 containing 10 % FBS. The
medium was replenished every 3–4 days after cell seed-
ing. On days 13–14, microglia were isolated by shaking
the flask at 250 rpm for 1 h as described [31]. Then, the
cells were centrifuged and seeded at the appropriate
density in six-well plates for further stimulation. After
the mixed glial cells were passaged two to three times
and shaken at 250 rpm for 6 h, the supernatants were
discarded; the remaining adherent cells that remained
consisted predominantly of astrocytes [32].
Isolation and culture of primary mouse brain
microvascular endothelial cells
Primary cerebral endothelial cells were prepared as pre-
viously described [33]. In brief, cortices from 7- to 8-
week-old C57BL/6J mice were isolated by removing the
cerebellum, striatum, optic nerves, and white matter.
The outer vessels and the meninges were removed using
dry cotton swabs. Then, the tissue sample was fragmen-
ted into 2-mm2-thick pieces and digested in 15 ml of
0.1 % collagen B (Roche, Indianapolis, IN, USA) supple-
mented with 30 U/ml DNase I (Sigma, St. Louis, MO,
USA) for 1.5–2 h at 37 °C with occasional agitation. The
suspension was centrifuged at 1000 rpm for 8 min. The
resulting homogenate was mixed with 20 % BSA in
DMEM and centrifuged at 4000 rpm for 20 min at 4 °C.
The neural component and the BSA layer were dis-
carded, and the pellet containing the vascular compo-
nent was further digested in 0.1 % collagenase/dispase
(Roche, Indianapolis, IN, USA) supplemented with 20
U/ml DNase I for 1.5–2 h at 37 °C. The final microvessel
pellets were resuspended in DMEM supplemented with30 % FBS (Life Technologies, Carlsbad, CA, USA), 3 ng/
ml bFGF (Peprotech, Rocky Hill, NJ, USA), 10 U/ml
heparin, 100 U/ml penicillin, and 100 mg/ml strepto-
mycin. The medium was refreshed every 2 days. The
endothelial cells grew to confluency after 7 days. The
purity of the endothelial cells was >93 %.
Generation of chimeric mice
Prior to irradiation, the mice were treated with antibiotics
with the intention of eliminating Pseudomonas aeruginosa
from the gastrointestinal tract. Neomycin was added to
the drinking water 2 weeks post-irradiation. The recipient
mice were lethally irradiated with two doses of 500 rad
(separated by 2–3 h) as previously described [34]. Bone
marrow cells were harvested from both the femora and
tibiae of the donor mice, and approximately 5–6 million
cells were intravenously injected into the recipient mice.
Bone marrow transfers were performed as follows: (1)
bone marrow cells from the CXCR2−/− mice were trans-
ferred into the wild-type (WT) mice (chimeric, expressing
CXCR2 on only the non-hematopoietic cells) and (2) bone
marrow cells from the WT mice were transferred into the
CXCR2−/− mice (chimeric, expressing CXCR2 on only the
hematopoietic cells). All chimeric mice were used for
intravital microscopy experiments 6–8 weeks after bone
marrow transfer.
CXCR2 blockade
To block endothelial CXCR2, WT mice were intra-
venously injected with CXCR2 antagonist SB225002
(Cayman, Ann Arbor, MI, USA) at a dose of 1 mg/kg
0.5 h prior to i.c.v. LPS injection [35]. The mice in the
control group were intravenously injected with 1 %
DMSO 0.5 h prior to i.c.v. LPS injection. SB225002 was
dissolved in DMSO and diluted with 0.9 % saline, achiev-
ing a final concentration of 1 % DMSO.
Statistical analysis
The data were analyzed using SPSS software (17.0 for
Windows, IBM Inc., Chicago, IL, USA). Data shown rep-
resent the means ± standard error of the mean (SEM).
Statistical significance was determined using Student’s t
tests for comparisons between two groups or by one-
way ANOVA with Bonferroni correction for multiple
groups of treatments. The differences were considered
to be significant when P < 0.05.
Results
Generation of TALEN-mediated CXCL1 knockout mice
To target the CXCL1 gene in the mouse genome,
TALEN constructs that targeted the DNA sequence of
the murine CXCL1 gene were created as illustrated in
Fig. 1A. The founders (#1, #2, and #3) from the new-
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Fig. 1 Generation of TALEN-mediated CXCL1 knockout mice. A DNA-binding sequences are presented in red or green, and the spacer region for
CXCL1-TALEN where a double-strand break will occur is underlined. B T7 endonuclease I (T7EI) assays were conducted using genomic DNA from
the founder mice. The arrow shows the size (300 bp) of T7EI-digested DNA fragments. #1, #2, and #3 are the mutant founder (F0) mice generated
by injection with CXCL1-TALEN mRNA. C DNA sequences of the CXCL1 locus from live founder mice identified by T7E1 assays in B. “-” shows the
deleted nucleotides. D Peripheral blood mononuclear cells and splenocytes were collected from wild-type or CXCL1−/− mice. Numbers of CD45+
and Gr.1+ cells were quantified via flow cytometry. E Peripheral blood mononuclear cells were collected from wild-type or CXCL1−/− mice, CXCR2
expression in neutrophils from WT and CXCR2−/− mice were analyzed via flow cytometry. F mRNA expression levels of TLR4 and CXCR2 in the
brain of WT or CXCL1−/− mice were analyzed by RT-PCR. G Wild-type and CXCL1−/− mice were treated with i.p. or i.c.v. LPS injection. Four hours
later, levels of TNF-α and IL-6 in the brain tissue or plasma were determined by ELISA. Data are expressed as the mean ± SEM, n = 4 mice in all of
the groups
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lengths that induced frameshifts in the CXCL1 gene.
Bi-allelic mutations were observed in three mutant
mice (Fig. 1C). CXCL1−/− mice were healthy, fertile,
displayed no overt phenotype, and had normal
leukocyte and neutrophil counts in the peripheral blood
and spleen (Fig. 1D). Flow cytometry also revealed that
neutrophils from CXCL1−/− mice expressed CXCR2 at a
similar level to wild-type mice (Fig. 1E). In addition,
CXCL1−/− mice showed normal TLR4 and CXCR2
mRNA expression levels in the brain (Fig. 1F). In re-
sponse to systemic or i.c.v. LPS treatment, IL-6 and
tumor necrosis factor-α (TNF-α) in the brain and
plasma were increased to a similar extent in both
CXCL1−/− and wild-type mice (Fig. 1G).
Intracerebroventricular injection of LPS induces
neutrophil recruitment and CXCL chemokine (CXCL1,
CXCL2, and CXCL5) expression
Intracerebroventricular injection of LPS strongly in-
duced the expression of inflammatory cytokines and
chemokines in the CNS. As shown in Fig. 2A–C, LPS in-
jection significantly induced the expression of CXCL
chemokines, including CXCL1, CXCL2, and CXCL5.
The levels of both CXCL1 (Fig. 2A) and CXCL2 (Fig. 2B)
gradually increased and peaked 8 h after LPS injection,
then gradually decreased thereafter. The level of CXCL5
(Fig. 2C) peaked at 16 h. Among all of these CXCL che-
mokines, CXCL1 exhibited the highest expression level
following LPS injection. The peak concentration of
CXCL5 was 10-fold less than that of CXCL1. At 12 h
after i.c.v. LPS injection, neutrophils began to migrate
into the brain. Infiltrating neutrophils, as detected by
esterase-specific staining, were observed 12 h post-
treatment in the cortex (Fig. 2D); this infiltration peaked
at 24 h in the cortex (Fig. 2D) and the hippocampus
(Fig. 2E) and decreased thereafter.
Deficiency in CXCR2 or CXCL1 affects neutrophil
infiltration induced by the i.c.v. injection of LPS
To investigate the role of CXCR2 in neutrophil recruit-
ment to the brain, we compared neutrophil infiltration
in the WT and CXCR2−/− mice after i.c.v. LPS injection(Fig. 2F). CXCR2−/− mice displayed significantly reduced
neutrophil infiltration into the cerebral cortical (Fig. 2G),
hippocampal regions (Fig. 2H) and choroid plexus
(Fig. 2I). As CXCL1 was most highly expressed during
LPS-induced CNS inflammation, we generated CXCL1-
deficient mice using the TALEN knockout technique
and compared neutrophil infiltration in these mice with
that in the WT mice. Interestingly, the CXCL1−/− mice
also exhibited a complete lack of neutrophil recruitment
to the cortex, the hippocampus, and choroid plexus
(Fig. 2G–I). Therefore, both CXCL1 and CXCR2 play
essential roles in LPS-induced neutrophil recruitment
into the brain.
Deficiency in CXCR2 or CXCL1 affects leukocyte
recruitment in brain vessels
Chemokines regulate immune cell trafficking by assisting
the activation, adhesion, crawling, and transmigration of
leukocytes across the cerebral endothelial barrier. To
verify the role of CXCR2 in the neutrophil recruitment
cascade in brain microvessels, we performed intravital
microscopy to examine leukocyte recruitment in brain
vessels during LPS-induced CNS inflammation. As
expected, i.c.v. LPS injection caused significant rolling
and adhesion of leukocytes in post-capillary venules in
brains of WT mice (Fig. 3A). Interestingly, leukocyte–
endothelial cell interactions appeared to be reduced in
the CXCR2−/− (Fig. 3B) and CXCL1−/− mice (Fig. 3C).
Rolling (Fig. 3D) and adherent cells (Fig. 3e) were almost
completely absent in the CXCR2−/−and CXCL1−/− mice,
indicating that both CXCL1 and CXCR2 are essential for
the leukocyte recruitment cascade in cerebral microves-
sels in the LPS-induced neuroinflammation.
CXCR2 deficiency decreases brain endothelial activation
in vivo
To investigate the molecular mechanisms underlying the
effects of CXCR2 and CXCL1 deficiency on leukocyte–
endothelial cell interactions, the expression of adhesion
molecules in CXCR2−/− and CXCL1−/− mice was assessed
via real-time PCR 4 h after i.c.v. LPS injection. Interest-
ingly, the mRNA expression levels of P-selectin (Fig. 4A),
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Fig. 2 Chemokine levels and the effect of CXCR2 or CXCL1 deficiency on neutrophil recruitment to the brain parenchyma after i.c.v. LPS injection.
Wild-type mice were i.c.v. injected with LPS. CXCL1 (A), CXCL2 (B), and CXCL5 (C) concentrations in the brains of WT (C57BL/6J) mice were deter-
mined via ELISA at various time points after i.c.v. LPS injection. WT mice i.c.v. injected with saline for 24 h served as negative controls. Infiltrating
neutrophils in the cortex (D) and hippocampus (E) were quantified via esterase staining of the brain sections 4, 12, 24, or 48 h after i.c.v. LPS or sa-
line injection. (F) The WT, CXCR2−/−, and CXCL1 mice were i.c.v. injected with LPS 24 h before the quantification of infiltrating neutrophils. Repre-
sentative photomicrographs of brain sections stained for esterase positive neutrophils (arrows) from wild-type, (G–I) CXCR2−/− and CXCL1 mice.
Scale bar: 100 μm; 10 μm (inset). CXCR2 and CXCL1 deficiency significantly reduced neutrophil recruitment in the cortex (G), hippocampus (H),
and choroid plexus (I). The results are presented as the means ± SEM and represent a minimum of five mice per group. *P < 0.05; **P < 0.01
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CXCL1−/− mice. Additionally, the protein expression
levels of these adhesion molecules were assessed by
Western blotting (Fig. 5A). Consistent with the real-
time PCR results, both CXCR2 deficiency and CXCL1
deficiency dramatically reduced the protein expression
of P-selectin (Fig. 5B) and VCAM-1 (Fig. 5C) in the
brain. A significant reduction in the levels of ICAM-1
(Fig. 5D) was also observed in the CXCR2−/− mice,
albeit to a lesser extent. Taken together, these results
suggest that both CXCR2 and CXCL1 are critical effec-
tors that mediate the expression of adhesion molecules
on cerebral endothelial cells during CNS inflammation.
It is well established that CNS inflammation induces





Fig. 3 CXCR2 deficiency causes decreased leukocyte rolling and adhesion in
on wild-type (A), CXCR2−/− (B), and CXCL1−/− mice (C) 4 h after LPS i.c.v. injectio
as the means ± SEM. n= 4–6 mice per group. **P< 0.01i.c.v. injection of LPS induced a significant change in
brain albumin concentration 12 and 24 h post-treatment
in both WT and CXCR2−/− mice. However, no signifi-
cant difference in albumin concentrations between the
WT and CXCR2−/− mice was observed 4, 12, and 24 h
after i.c.v. LPS injection (Fig. 5E). Therefore, it is likely
that rather than affecting the integrity of blood–brain
barrier, CXCR2 deficiency affected neutrophil recruit-
ment by attenuating endothelial activation.
CXCR2 expression on CNS-residing cells mediates endothelial
activation and leukocyte recruitment in chimeric mice
To identify the source of functional CXCR2 that medi-
ates leukocyte recruitment, we generated chimeric mice
by transferring bone marrow cells between WT andE
40µm
 -/- CXCL1 -/-
C
brain vessels after i.c.v. LPS injection. Intravital microscopy was performed
n. The results of rolling flux (D) and leukocyte adhesion (E) are presented
Fig. 4 The effect of CXCR2 or CXCL1 deficiency on the mRNA expression of adhesion molecules in vivo. The mRNA expression of P-selectin, E-selectin,
VCAM-1, and ICAM-1 saline-treated (4 h after i.c.v. saline injection) control group of WT mice and LPS-treated (4 h after i.c.v. LPS injection) WT, CXCR2−/−,
and CXCL1−/− mice was quantified via real-time PCR. Both CXCR2 and CXCL1 deficiency resulted in the down-regulation of P-selectin (A), E-selectin (B),
VCAM-1 (C), and ICAM-1 (D) mRNA expression in the brain. n= 6–8 mice for all groups. *P< 0.05; **P< 0.01
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performed on all chimeric mice 4 h after i.c.v. LPS injec-
tion. CXCR2−/− mice that were reconstituted using WT
bone marrow cells exhibited reduced leukocyte rolling
and adhesion. By contrast, the chimeric mice generated
by reconstituting the WT mice using CXCR2−/− bone
marrow cells exhibited normal leukocyte recruitment to
the cerebral microvessels (Fig. 6B). Consistent with our
observations from intravital microscopy, the CXCR2−/−
mice reconstituted with WT bone marrow cells dis-
played significantly reduced levels of P-selectin and
VCAM-1 expression, whereas the levels of P-selectin
and VCAM-1 expression in the WT mice reconstituted
using CXCR2−/− bone marrow cells were almost similar
to that of WT mice (Fig. 6C).
Astrocyte-derived CXCL1 and endothelial CXCR2 are
important in cerebral endothelial activation
The reductions in endothelial activation and subsequent
leukocyte–endothelial cell interactions in CNS microvesselsresulted from a lack of CXCR2 expression on CNS-residing
cells, but not on circulating neutrophils. Therefore, the
functional CXCR2 that mediates endothelial activation is
likely localized to radiation-resistant non-hematopoietic
cells, such as endothelial or glial cells. LPS i.c.v. injection
induced significant levels of CXCR2 mRNA (Fig. 7A) and
protein (Fig. 7B). Upon TNF-α stimulation, primary endo-
thelial cells, compared with glial cells, exhibited much
higher expression of CXCR2 mRNA. No significant change
in CXCR2 transcription was noted in primary microglia or
astrocytes (Fig. 7C). Following stimulation with TNF-α or
LPS, the cerebral endothelial cells, compared with astro-
cytes and microglia, also expressed much higher level of
CXCR2 protein (Fig. 7D). Astrocytes secreted much higher
levels of CXCL1 than microglia in response to TNF-α and
LPS (Fig. 7E). Astrocyte culture conditioned medium stim-
ulated strong expression of VCAM-1 and ICAM-1 in WT
cerebral endothelial cells. Reduced expression of these mol-
ecules was observed in CXCR2−/− endothelial cells (Fig. 7F).
These results suggest that astrocyte-derived CXCL1 and
Fig. 5 Effects of CXCR2 or CXCL1 deficiency on the expression of P-selectin, E-selectin, and adhesion molecules in vivo and on BBB permeability.
a The protein expression of P-selectin, E-selectin, VCAM-1, and ICAM-1 (4 h after i.c.v. saline injection) in the saline-treated control group of WT
mice and LPS-treated (4 h after i.c.v. LPS injection) WT, CXCR2−/−, and CXCL1−/− mice was determined via Western blot analysis. Effects of CXCR2
or CXCL1 deficiency on P-selectin (b), VCAM-1 (c), and ICAM-1 (d) expression in the brain. e Western blotting analysis of the albumin levels in the brains
of WT and CXCR2−/− mice 4, 12, and 24 h after the intraventricular injection of LPS was performed. Optical densities were determined using a com-
puter imaging analysis system. n = 5 mice per group. **P < 0.01; ***P < 0.001
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thelial activation.
Effect of CXCR2 blockade on leukocyte recruitment and
endothelial activation
To validate the critical role of endothelial CXCR2 in
cerebral endothelial activation, we intravenously infused
the CXCR2 antagonist SB225002 at a dose of 1 mg/kg
0.5 h prior to i.c.v. LPS injection to block CXCR2 signaling
[35] from the luminal surface of the cerebral microvessels.
As detected by Western blotting, SB225002 treatment
decreased the levels of VCAM-1 and E-selectin expression
but not that of P-selectin (Fig. 8A). In addition, intravital
microscopy also revealed that the injection of SB225002
significantly decreased leukocyte rolling and adhesion in
brain microvessels (Fig. 8B). These results further indicatethat endothelial CXCR2 plays a critical role in endothelial
activation and subsequent leukocyte recruitment.
Discussion
Leukocyte recruitment is a hallmark of various CNS in-
flammatory diseases. The chemokine receptor CXCR2
and its ligands CXCL1, CXCL2, and CXCL5 play crucial
roles in the trafficking of neutrophils. In the current
study, we showed that LPS injection into the brain
significantly induced the production of CXCL1, CXCL2,
and CXCL5. CXCL1, the most potent neutrophil-
chemoattracting CXCR2 ligand, was upregulated in the
CNS at the earliest time point and was correspondingly
expressed at the highest level. The i.c.v. injection of LPS
has been widely applied as an animal model for the
study of brain inflammation. The dosage of 2 μg of LPS
Fig. 6 Leukocyte recruitment and the expression of P-selectin and VCAM-1 in the WT, CXCR2−/−, and chimeric mice. a Chimeric mice were generated
by transferring bone marrow cells between WT and CXCR2−/− mice. b Intravital microscopy was performed on WT, CXCR2−/−, and chimeric mice, 4 h
after i.c.v. LPS injection. The number of rolling and adherent leukocytes is presented as the mean ± SEM. c The expression of P-selectin and VCAM-1 in
the WT, CXCR2−/−, and chimeric mice was compared by Western blotting, n = 4 mice per group. Data are presented as the means ± SEM,
*P < 0.05; **P < 0.01
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tions and results in robust neutrophil recruitment. How-
ever, a significant reduction in the number of infiltrating
neutrophils was observed in the brain parenchyma of
CXCR2−/− and CXCL1−/− mice after i.c.v. LPS injection.
Therefore, CXCL1 acts as the principal mediator of neutro-
phil recruitment during LPS-induced CNS inflammation.
The leukocyte recruitment cascade in brain vessels is
directed by the complex interactions between adhesion
molecules and their receptors [36, 37]. Intravital micros-
copy revealed that a deficiency in either CXCR2 or
CXCL1 significantly reduced leukocyte–endothelial cell
interactions in brain vessels. Additionally, reduced
expression of P-selectin, VCAM-1, and ICAM-1 was
observed in the brain of CXCR2−/− mice. Therefore, it is
likely that the functional CXCR2 that mediates leukocyterecruitment is located on the CNS endothelium. Our
previous study reported that TNF-α in the LPS-treated
brain activated the endothelium to cause an increase in
adhesion molecule expression and leukocyte recruitment
[29]. In response to i.c.v. LPS injection, CXCR2 defi-
ciency did not reduce TNF-α levels in the brain. Clearly,
a deficiency in CXCR2 or CXCL1 directly affected cere-
bral endothelial activation, but not microglial activation.
In addition to its chemotactic properties, CXCL1 also
exerts direct effects on BBB permeability. The exposure
of brain microvascular endothelial cells to CXCL1 in
vitro altered endothelial permeability and facilitated
transendothelial monocyte migration [38]. However, in
our study, CXCR2 deficiency did not affect albumin
leakage across the BBB. Therefore, the reduction in neu-
trophil infiltration was not due to a change in the
Fig. 7 Astrocyte-derived CXCL1 and endothelial CXCR2 are essential for cerebral endothelial activation. A i.c.v. LPS injection (4 h) induced
significant CXCR2 mRNA expression in WT mice. B Levels of CXCR2 protein after i.c.v. LPS injection from 4 to 24 h gradually increased compared
with the control group (4 h after i.c.v. saline injection). C The expression of CXCR2 mRNA in primary brain microvascular endothelial cells,
microglia, and astrocytes stimulated with either vehicle or TNF-α (100 ng/ml) was measured via real-time PCR. The results are represented as the
means ± SEM of three independent experiments; *P < 0.05. D Primary endothelial cells, astrocytes, and microglia were seeded at 2 × 106 cells/well
in six-well plates and were incubated overnight. The following day, the cells were stimulated with 100 ng/ml LPS or 100 ng/ml TNF-α for 12 h.
Cell lysates were collected and analyzed for CXCR2 expression via Western blotting. E Primary astrocytes and microglia from wild-type mice were
seeded at 2 × 106 cells/well in six-well plates and were incubated overnight. The following day, the cells were stimulated with 100 ng/ml LPS or
100 ng/ml TNF-α for 12 h. Then, the conditioned supernatants and cell lysates were collected and analyzed for CXCL1 expression via ELISA. The
results are represented as the means ± SEM of three independent experiments; **P < 0.01. F Astrocyte culture conditioned medium was added
into primary cerebral endothelial cells from wild-type or CXCR2−/− mice, and the levels of VCAM-1 and ICAM-1 were measured via
Western blotting
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activation resulting from CXCL1 or CXCR2 deficiency.
Among the chimeric mice generated by transferring
bone marrow precursors between CXCR2−/− and WT
mice, WT mice reconstituted using CXCR2−/− bone
marrow cells exhibited normal cell recruitment to thebrain vessels. Interestingly, functional CXCR2 is not
expressed on circulating leukocytes from the bone mar-
row. Therefore, the activation of CXCR2 on leukocytes
is not required for their recruitment in cerebral blood
vessels. Earlier studies have identified the expression of
CXCR2 on many types of CNS-residing cells [39–41].
Fig. 8 The effect of CXCR2 antagonist infusion on leukocyte rolling and adhesion in CNS vessels. WT mice received an intravenous injection of
the CXCR2 antagonist SB225002 (1 mg/kg) 0.5 h prior to i.c.v. LPS injection. Four hours after i.c.v. LPS injection, the protein expression of P-
selectin, VCAM-1, and E-selectin in the brain was determined by Western blot analysis (A). Intravital microscopy was performed on the mice. The
results of leukocyte recruitment (B) are presented as the mean ± SEM. n = 4 mice for all groups. *P < 0.05; **P < 0.01
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CXCR2 on CNS-residing cells, including endothelial
cells, astrocytes, and microglia, is more important
than its expression on circulating cells during CNS
inflammation. Moreover, TNF-α robustly induced a
high expression of CXCR2 mRNA in primary murine
endothelial cells, but not in primary microglia or
astrocytes. High levels of expression of the CXCR2
mRNA and protein were detected in wild-type cere-
bral endothelial cells, which strongly indicates that
endothelial CXCR2 is a key player mediating cerebral
endothelial activation. To further validate the role of
endothelial CXCR2, we intravenously injected SB225002
to block the function of CXCR2 in brain endothelial cells,
as SB225002 in the blood circulation can easily access
the brain endothelium. Compared with mice treated
with LPS alone, both cerebral endothelial activation
and leukocyte recruitment in the cerebral vessels were
reduced in the mice treated with both SB225002 and
LPS. Taken together, these data indicate that SB225002
potently inhibited CXCR2 function on brain endothelial
cells, thereby blocked leukocyte recruitment.
Astrocytes, which are more abundant than microglia
in the brain [42], released much higher levels of CXCL1
than microglia in response to stimulation with LPS or
TNF-α. Our study confirmed that astrocytes released
significantly higher levels of CXCL1 than microglia in
response to stimulation with LPS or TNF-α, suggesting
that the main source of CXCL1 may be astrocytes.
CXCL1 deficiency reduced leukocyte recruitment and
endothelial activation by over 50 % in vivo. Astrocytes
are essential structural components of the BBB [43, 44];
among all cell types in the brain, they have the easiest
access to the brain endothelium and can release
CXCL1, which possibly accumulate in the perivascular
space at an extremely high concentration to activate cere-
bral endothelial cells. Therefore, the CXCL1 secreted fromastrocytes and CXCR2 expressed on the endothelium may
cooperate in contributing to cerebral endothelial activa-
tion and the subsequent leukocyte recruitment cascade
during CNS inflammation.Conclusions
Endothelial activation is a critical step in the process of
leukocyte recruitment during CNS inflammation. In the
current study, we found that either CXCR2 or CXCL1
deficiency resulted in reduced neutrophil infiltration
and leukocyte–endothelial cell interactions in the brain.
A dramatic reduction in the endothelial expression of
adhesion molecules was also noted in these mice. Our
results demonstrate that CXCL1, an important factor
secreted by astrocytes, also plays a critical role in
leukocyte recruitment to the CNS by cooperating with
CXCR2 expressed on cerebral endothelial cells. The
CXCL1-CXCR2 axis may represent another potential
therapeutic target for the treatment of CNS inflamma-
tory diseases.Abbreviations
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